Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.6800
-0.0200 (-2.86%)
Jul 29, 2025, 2:55 PM AEST

Argenica Therapeutics Revenue

Argenica Therapeutics had revenue of 2.83M AUD in the half year ending December 31, 2024, with 105.66% growth. This brings the company's revenue in the last twelve months to 3.08M, up 13.03% year-over-year. In the fiscal year ending June 30, 2024, Argenica Therapeutics had annual revenue of 2.60M with 48.46% growth.

Revenue (ttm)
3.08M
Revenue Growth
+13.03%
P/S Ratio
28.36
Revenue / Employee
n/a
Employees
n/a
Market Cap
87.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20242.60M848.04K48.46%
Jun 30, 20231.75M1.49M575.38%
Jun 30, 2022259.10K-36.98K-12.49%
Jun 30, 2021296.08K--
Jun 30, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CSL Limited24.61B
Pro Medicus184.58M
Cochlear2.31B
Sonic Healthcare9.33B
Ramsay Health Care17.12B
Telix Pharmaceuticals783.21M
Ansell3.00B
Mesoblast9.16M
Revenue Rankings